Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05063474 · ClinicalTrials.gov registry record
Microvascular Reactivity in Peripheral Artery Disease
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 3
- Enrollment target
NCT05063474 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 3 participants.
The verdict
NCT05063474 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Peripheral Artery Disease (PAD) is a major risk factor for lower limb amputation. Microvascular reactivity assessed with near-infrared spectrometry has been studied in people with PAD but not in people with limb loss (PLL) who have PAD. The purpose of this research is to explore whether near-infrared spectrometry measures can contribute to identifying people at risk for amputation. Specific aims include: 1) Determine the test-retest reliability of near-infrared spectrometry measures in people with peripheral artery disease with or without major unilateral amputation. 2) Determine construct validity of near-infrared spectrometry measures compared to 6-Minute Walk Test, and time to claudication onset; and self-reported prosthetic mobility in people with transtibial amputation. This methodologic prospective study with repeated assessments and long term phone follow-up every year to identify any subjects that undergo revascularization or amputation will include 2 groups of subjects: a PAD group enrolled from an out-patient walking program, and a PLL+PAD group who receive no care but have their walking step counts monitored.
Interventions
- DIAGNOSTIC_TEST No Intervention-Clinical Assessments only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2023-04-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05063474
The ClinicalTrials.gov registry entry for NCT05063474 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention-Clinical Assessments only is the first listed.
NCT05063474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05063474 about?
NCT05063474 is a clinical study titled "Microvascular Reactivity in Peripheral Artery Disease". Peripheral Artery Disease (PAD) is a major risk factor for lower limb amputation. Microvascular reactivity assessed with near-infrared spectrometry has been studied in people with PAD but not in people with limb loss (PLL) who have PAD. The purpose of this research is to explore whether near-infrare...
What is the current status of trial NCT05063474?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2021-11-09. Estimated completion is 2023-04-24.
What interventions are being tested in trial NCT05063474?
The interventions under investigation include: No Intervention-Clinical Assessments only (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05063474?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.